3D Systems (DDD) PT Raised to $16 at BofA Securities on Dental Printing Upside
- Dow, S&P post worst week in months after hawkish Fed spooks investors
- Fed-fueled dollar rises as bears make for exits
- Adobe (ADBE) Edges Higher After Topping Q2 Estimates, Analysts Raise PT on 'Impressive' Performance
- Fed Statement Very Bullish for Tech Stocks, Focus on Cloud and Cyber Stocks - Wedbush
- You Fight Real Physical Inflation With Rate Hikes, Not Talk of Rate Hikes; Buy the Dip in Commodities, Gold Underpriced - Goldman Sachs
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
BofA Securities analyst Wamsi Mohan raised the price target on 3D Systems (NYSE: DDD) to $16.00 (from $14.00) after the company reported 1Q revs of $146.1mn +7.7% y/y, above Street est. of $136.7mn. Healthcare grew +38.7% y/y driven by sales in dental and medical applications, while Industrial marginally grew +0.7% y/y excl. divestitures. Strong printer sales into the dental market was a key source of upside but will likely prove lumpy as demand hits tougher comps. Management noted a 50% expansion of the Denver Healthcare facility and expects investments in space, capacity, machines, and personnel to support long term growth.
The analyst reiterated a Buy rating, stating "Our F21/22 revs go to $597/615mn from $583/600mn, while EPS ests go to $0.29/0.22 from $0.21/0.23. Our PO moves to $16 (from $14), based on 3x (unchanged) EV/C22 rev estimate." "We continue to look for signs of tangible revenue impact stemming from recent acquisitions and investment in core businesses. We reiterate our Underperform rating due to COVID related uncertainty, and view Q1 as early days in a longer term turnaround. We look for more long-term color at the analyst day in Sep."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Barclays Downgrades Arcturus Therapeutics (ARCT) to Underweight, 'High Risk of Covid-19 Vaccine Failure'
- UPDATE: BofA Securities Starts Flywire (FLYW) at Buy
- Orpea (ORP:FP) (ORPEF) PT Raised to EUR108 at Berenberg
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!